Fish and its multiple human health effects in times of threat to sustainability and affordability: Are there alternatives?

Asia Pacific Journal of Clinical Nutrition

Volumn 18, Issue 4, 2009, Pages 553-563

  Li, Duo ^a,b   Hu, Xiaojie ^a,b  

^a ZHEJIANG UNIVERSITY   (China)

^b Centre of Nutrition and Food Safety   (China)

Author keywords

Aquaculture; Aquatic products; Contaminant; Fishing moratorium; Sustainability

Indexed keywords

OMEGA 3 FATTY ACID;

ANIMAL; AQUACULTURE; CHINA; ECONOMICS; FISH; FOOD ANALYSIS; FOOD CONTAMINATION; FOOD POISONING; HUMAN; METHODOLOGY; REVIEW; SEA FOOD; SHELLFISH;

ANIMALS; AQUACULTURE; CHINA; FATTY ACIDS, OMEGA-3; FISHES; FOOD ANALYSIS; FOOD CONTAMINATION; FOODBORNE DISEASES; HUMANS; SEAFOOD; SHELLFISH;

EID: 77649262502     PISSN: 09647058     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (69)

1. Mitchell DC, Gawrisch K, Litman BJ, Salem N Jr. Why is docosahexaenoic acid essential for nervous system function? Biochem Soc Trans. 1998;26:365-70.
2. Salem N Jr, Ward GR. Are omega-3 fatty acids essential nutrients for mammals? World Rev Nutr Diet. 1993;72:128-47.
3. Weisinger HS, Vingrys AJ, Bui BV, Sinclair AJ. Effects of dietary n-3 fatty acid deficiency and repletion in the guinea pig retina. Invest Ophthalmol Vis Sci. 1999;40:327-38.
4. Greiner RS, Moriguchi T, Hutton A, Slotnick BM, Salem N. Rats with low levels of brain docosahexaenoic acid show impaired performance in olfactory-based and spatial learning tasks. Lipids. 1999;34:S239-S243.
5. Salem N, Litman B, Kim HK, Gawrisch K. Mechanisms of action of docosahexaenoic acid in the nervous system. Lipids. 2001;36:945-59.
6. Kurlack LO, Stephenson TJ. Plausible explanations for effects of long chain polyunsaturated fatty acids on neonates. Arch Dis Child Fetal Neonatal Ed. 1999;80:148-54.
7. Hibbeln JR, Salem N Jr. Dietary polyunsaturated fatty acids and depression: when cholesterol does not satisfy. Am J Clin Nutr. 1995;62:1-9.
8. Li D, O Bode, H Drummond, Sinclair AJ. Chapter 8: Omega-3 (n-3) fatty acids. In: Gunstone FD, editor. Lipids for functional foods and nutraceuticals. London: The Oily Press; 2002. p. 225-62.
9. Curtis CL, Hughes CE, Flannery CR, Little CB, Harwood JL and Caterson B. n-3 fatty acids specifically modulate catabolic factors involved in articular cartilage degradation. J Biol Chem. 2000;275:721-4.
10. Clarke SD, Jump DB. Dietary polyunsaturated fatty acid regulation of gene transcription. Ann Rev Nutr. 1994;14:83-98.
11. Pegorier JP. Regulation of gene expression by fatty acids. Curr Opin Clin Nutr Metab Care. 1998;1:329-34.
12. Ren B, Thelen AP, Peters JM, Gonzalez FJ, Jump DB. Polyunsaturated fatty acid suppression of hepatic fatty acid synthase and S14 gene expression does not require peroxisome proliferator-activated receptor alpha. J Biol Chem. 1997;272:26827-32.
13. Price PT, Nelson CM, Clarke SD. Omega-3 polyunsaturated fatty acid regulation of gene expression. Curr Opin Lipidol. 2000;11:3-7.
14. Kitajka K, Sinclair AJ, Weisinger RS, Weisinger HS, Mathai M, Jayasooriya AP, Halver JE, Puskás LG. Effects of dietary omega-3 polyunsaturated fatty acids on brain gene expression. Proc Natl Acad Sci USA. 2004;101:10931-6.
15. Griffin MD, Sanders TA, Davies IG, Morgan LM, Millward DJ, Lewis F, Slaughter S, Cooper JA, Miller GJ, Griffin BA. Effects of altering the ratio of dietary n-6 to n-3 fatty acids on insulin sensitivity, lipoprotein size, and postprandial lipemia in men and postmenopausal women aged 45-70 y: the OPTILIP Study. Am J Clin Nutr. 2006;84:1290-8.
16. Kelley DS, Siegel D, Vemuri M, Mackey BE. Docosahexaenoic acid supplementation improves fasting and postprandial lipid profiles in hypertriglyceridemic men. Am J Clin Nutr. 2007;86:324-33.
17. Morris MC, Sack F, Rosner B. Does fish oil lower blood pressure? A meta-analysis of controlled trials. Circulation. 1993;88:523-33.
18. Erkkilä AT, Schwab US, de Mello VD, Lappalainen T, Mussalo H, Lehto S, Kemi V, Lamberg-Allardt C, Uusitupa MI. Effects of fatty and lean fish intake on blood pressure in subjects with coronary heart disease using multiple medications. Eur J Nutr. 2008;47:319-28.
19. Geelen A, Brouwer IA, Schouten EG, Maan AC, Katan MB, Zock PL. Effects of n-3 fatty acids from fish on premature ventricular complexes and heart rate in humans. Am J Clin Nutr. 2005;81:416-20.
20. O'Keefe JH Jr, Abuissa H, Sastre A, Steinhaus DM, Harris WS. Effects of omega-3 fatty acids on resting heart rate, heart rate recovery after exercise, and heart rate variability in men with healed myocardial infarctions and depressed ejection fractions. Am J Cardiol. 2006;97:1127-30.
21. Christensen JH, Skou HA, Madsen T, Torring I, Schmidt EB. Heart rate variability and n-3 polyunsaturated fatty acids in patients with diabetes mellitus. J Intern Med. 2001; 249:545-52.
22. Holguin F, Téllez-Rojo MM, Lazo M, Mannino D, Schwartz J, Hernández M, Romieu I. Cardiac autonomic changes associated with fish oil vs soy oil supplementation in the elderly. Chest. 2005;127:1102-7.
23. Morgan DR, Dixon LJ, Hanratty CG, El-Sherbeeny N, Hamilton PB, McGrath LT, Leahey WJ, Johnston GD, McVeigh GE. Effects of dietary omega-3 fatty acid supplementation on endothelium-dependent vasodilation in patients with chronic heart failure. Am J Cardiol. 2006;97: 547-51.
24. Calò L, Bianconi L, Colivicchi F, Lamberti F, Loricchio ML, de Ruvo E, Meo A, Pandozi C, Staibano M, Santini M. N-3 Fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a randomized, controlled trial. Am Coll Cardiol. 2005;45:1723-8.
25. Yokoyama M, Origasa H, Matsuzaki M, Matsuzawa Y, Saito Y, Ishikawa Y et al. Japan EPA lipid intervention study (JELIS) Investigators. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet. 2007;369:1090-8.
26. Gissi-HF Investigators, Tavazzi L, Maggioni AP, Marchioli R, Barlera S, Franzosi MG et al. Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebocontrolled trial. Lancet. 2008;372:1223-30.
27. Leaf A, Albert CM, Josephson M, Steinhaus D, Kluger J, Kang JX, Cox B, Zhang H, Schoenfeld D. Fatty Acid Antiarrhythmia Trial Investigators. Prevention of fatal arrhythmias in high-risk subjects by fish oil n-3 fatty acid intake. Circulation. 2005;112:2762-8.
28. Metcalf RG, Sanders P, James MJ, Cleland LG, Young GD. Effect of dietary n-3 polyunsaturated fatty acids on the inducibility of ventricular tachycardia in patients with ischemic cardiomyopathy. Am J Cardiol. 2008;101:758-61.
29. Leaf A, Xiao YF, Kang JX, Billman GE. Membrane effects of the n-3 fish oil fatty acids, which prevent fatal ventricular arrhythmias. J Membr Biol. 2005;206:129-39.
30. Kremer JM, Lawrence DA, Petrillo GF, Litts LL, Mullaly PM, Rynes RI, Stocker RP, Parhami N, Greenstein NS, Fuchs BR. Effects of high-dose fish oil on rheumatoid arthritis after stopping nonsteroidal antiinflammatory drugs. Clinical and immune correlates. Arthritis Rheum. 1995;38: 1107-14.
31. Sundrarjun T, Komindr S, Archararit N, Dahlan W, Puchaiwatananon O, Angthararak S, Udomsuppayakul U, Chuncharunee S. Effects of n-3 fatty acids on serum interleukin-6, tumour necrosis factor-alpha and soluble tumour necrosis factor receptor p55 in active rheumatoid arthritis. J Int Med Res. 2004;32:443-54.
32. Galarraga B, Ho M, Youssef HM, Hill A, McMahon H, Hall C, Ogston S, Nuki G, Belch JJ. Cod liver oil (n-3 fatty acids) as an non-steroidal anti-inflammatory drug sparing agent in rheumatoid arthritis. Rheumatology. 2008;47:665-9.
33. Olsen SF, Østerdal ML, Salvig JD, Mortensen LM, Rytter D, Secher NJ, Henriksen TB. Fish oil intake compared with olive oil intake in late pregnancy and asthma in the offspring: 16 y of registry-based follow-up from a randomized controlled trial. Am J Clin Nutr. 2008;88:167-75.
34. Mickleborough TD, Lindley MR, Ionescu AA, Fly AD. Protective effect of fish oil supplementation on exerciseinduced bronchoconstriction in asthma. Chest. 2006;129:39-49.
35. Matsuyama W, Mitsuyama H, Watanabe M, Oonakahara K, Higashimoto I, Osame M, Arimura K. Effects of omega-3 polyunsaturated fatty acids on inflammatory markers in COPD. Chest. 2005;128:3817-27.
36. Vedin I, Cederholm T, Freund Levi Y, Basun H, Garlind A, Faxén Irving G, Jönhagen ME, Vessby B, Wahlund LO, Palmblad J. Effects of docosahexaenoic acid-rich n-3 fatty acid supplementation on cytokine release from blood mononuclear leukocytes: the OmegAD study. Am J Clin Nutr. 2008;87:1616-22.
37. Kelley DS, Siegel D, Fedor DM, Adkins Y, Mackey BE. DHA supplementation decreases serum C-reactive protein and other markers of inflammation in hypertriglyceridemic men. J Nutr. 2009;139:495-501.
38. Krauss-Etschmann S, Hartl D, Rzehak P, Heinrich J, Shadid R, Del Carmen Ramírez-Tortosa M et al. Nutraceuticals for Healthier Life Study Group. Decreased cord blood IL-4, IL-13, and CCR4 and increased TGF-beta levels after fish oil supplementation of pregnant women. J Allergy Clin Immunol. 2008;121:464-70.
39. Adams PB, Lawson S, Sanigorski A, Sinclair AJ. Arachidonic acid to eicosapentaenoic acid ratio in blood correlates positively with clinical symptoms of depression. Lipids. 1996;31:S157-S161.
40. Maes M, Christophe A, Delanghe J, Altamura C, Neels H, Meltzer HY. Lowered omega3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients. Psychiatry Res. 1999;85:275-91.
41. Laasonen M, Hokkanen L, Leppämäki S, Tani P, Erkkilä AT. Project DyAdd: Fatty acids in adult dyslexia, ADHD, and their comorbid combination. Prostaglandins Leukot Essent Fatty Acids. 2009;81:89-96.
42. Richardson AJ, Easton T, Puri BK. Red cell and plasma fatty acid changes accompanying symptom remission in a patient with schizophrenia treated with eicosapentaenoic acid. Eur Neuropsychopharmacol. 2000;10:189-93.
43. Assies J, Lieverse R, Vreken P, Wanders RJ, Dingemans PM, Linszen DH. Significantly reduced docosahexaenoic and docosapentaenoic acid concentrations in erythrocyte membranes from schizophrenic patients compared with a carefully matched control group. Biol Psychiatry. 2001;49: 510-22.
44. Samieri C, Féart C, Letenneur L, Dartigues JF, Pérès K, Auriacombe S, Peuchant E, Delcourt C, Barberger-Gateau P. Low plasma eicosapentaenoic acid and depressive symptomatology are independent predictors of dementia risk. Am J Clin Nutr. 2008;88:714-21.
45. Schaefer EJ, Bongard V, Beiser AS, Lamon-Fava S, Robins SJ, Au R, Tucker KL, Kyle DJ, Wilson PW, Wolf PA. Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study. Arch Neurol. 2006;63:1545-50.
46. Lucas M, Asselin G, Mérette C, Poulin MJ, Dodin S. Ethyleicosapentaenoic acid for the treatment of psychological distress and depressive symptoms in middle-aged women: a double-blind, placebo-controlled, randomized clinical trial. Am J Clin Nutr. 2009;89:641-51.
47. Nemets H, Nemets B, Apter A, Bracha Z, Belmaker RH. Omega-3 treatment of childhood depression: a controlled, double-blind pilot study. Am J Psychiatry. 2006;163:1098-100.
48. Freund-Levi Y, Eriksdotter-Jönhagen M, Cederholm T, Basun H, Faxén-Irving G, Garlind A, Vedin I, Vessby B, Wahlund LO, Palmblad J. Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial. Arch Neurol. 2006;63:1402-8.
49. Birch EE, Garfield S, Castañeda Y, Hughbanks-Wheaton D, Uauy R, Hoffman D. Visual acuity and cognitive outcomes at 4 years of age in a double-blind, randomized trial of longchain polyunsaturated fatty acid-supplemented infant formula. Early Hum Dev. 2007;83:279-84.
50. Hoffman DR, Theuer RC, Castañeda YS, Wheaton DH, Bosworth RG, O'Connor AR, Morale SE, Wiedemann LE, Birch EE. Maturation of visual acuity is accelerated in breast-fed term infants fed baby food containing DHA-enriched egg yolk. J Nutr. 2004;134:2307-13.
51. SanGiovanni JP, Chew EY, Clemons TE, Davis MD, Ferris FL 3rd, Gensler GR et al. Age-Related Eye Disease Study Research Group.The relationship of dietary lipid intake and age-related macular degeneration in a case-control study: AREDS Report No. 20. Arch Ophthalmol. 2007;125:671-9.
52. Augood C, Chakravarthy U, Young I, Vioque J, de Jong PT, Bentham G et al. Oily fish consumption, dietary docosahexaenoic acid and eicosapentaenoic acid intakes, and associations with neovascular age-related macular degeneration. Am J Clin Nutr. 2008;88:398-406.
53. SanGiovanni JP, Chew EY, Agrón E, Clemons TE, Ferris FL 3rd, Gensler G et al. Age-Related Eye Disease Study Research Group. The relationship of dietary omega-3 longchain polyunsaturated fatty acid intake with incident agerelated macular degeneration: AREDS report no. 23. Arch Ophthalmol. 2008;126:1274-9.
54. Lou D, Zhu BJ. The Evolution of Space Pattern and Industrial Structure of Chinese Fishery. Chinese Fisheries Economy Research. 2005;2:21-4. (in Chinese)
55. National Bureau of Statistics. China Statistical Yearbook. 2008, China Statistical Publishing House, Beijing.
56. Cheng JC, Gao J, Liu J. Policy transition in China's fishery and its role in keeping balance of aquatic products between production and demand in the future. J Beijing Fisheries. 2005;4:4-6. (in Chinese)
57. National Bureau of Statistics. China Statistical Yearbook. 2007, China Statistical Publishing House, Beijing.
58. National Bureau of Statistics. China Statistical Yearbook. 2003, China Statistical Publishing House, Beijing.
59. National Bureau of Statistics. China Statistical Yearbook. 2004, China Statistical Publishing House, Beijing.
60. Yang XL. Drug residues in aquatic products and the scientific management and use of fishery drugs. China Fisheries. 2002;11:74-5. (in Chinese)
61. McGregor DB, Partensky C, Wilbourn J, Rice JM. An IARC evaluation of polychlorinated dibenze-p-dioxins and polychlorinated dibenzefurans as risks factors in human carcinogenesis. Environ Health Perspect. 1998;106(S2):755-60.
62. Wu Y, Li J, Zhao Y, Chen Z, Li W, Chen J. Dietary intake of polychloranited dibenzo-p-dioxins (PCDDs) and dibenzo furans (PCDFs) in populations from China. Organohalog Compd. 2002;57:221-3.
63. Van Overmeire I, Van Loco J, Roos P, Carbonnelle S, Goeyens L. Interpretation of CALUX results in view of the EU maximal TEQ level in milk. Talanta. 2004;63:1241-7.
64. Zhang JQ, Zhou J, Jiang YS, Jiang J, Zhuang ZX, Wu YN. Investigation on PCDD/Fs contamination level in 31 fish samples from a typical water area. Modern Prevent Med. 2005;32:577-83. (in Chinese)
65. Chu SG, Xu XB, Cai ML. Determination of coplanar (nonortho substituted) polychlorinated biphenyls in environmental samples. Environ Chem. 1997;16:327-32. (in Chinese)
66. Wang T, Li XC. Detection of PCBs in aquatic products and international trade of aquatic products. China Fisheries. 2005;7:20-1. (in Chinese)
67. Yu Q, Li YM, Zhang H, Zhang HM, Cong LY, Luo LM, Wang KQ, Xu XR, Liu XM. Determination of organochlorine pesticides and polychlorinated biphenyls in mussel and oyster by gas chromatography. J Instrum Anal. 2002;21:90-3. (in Chinese)
68. Zhang YZ, Wang GJ. Evaluation of heavy metals in aquatic product in the market of major cities in Zhejiang Province. Guangdong Trace Elem Sci. 2004;11:56-9. (in Chinese)
69. Shao GL, Cheng Y. Considerations on the export of Chinese aquatic products. J Intern Trade. 2005;8:31-4. (in Chinese)